Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Assessing Care and Health Outcomes Among Ryan White HIV/AIDS Program Clients Who Do Not Receive RWHAP-Funded Outpatient Ambulatory Health Services, OMB No. 0906-xxxx-NEW, 32752-32753 [2019-14535]
Download as PDF
<![CDATA[
32752
Federal Register / Vol. 84, No. 131 / Tuesday, July 9, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; Assessing Care and Health
Outcomes Among Ryan White HIV/
AIDS Program Clients Who Do Not
Receive RWHAP-Funded Outpatient
Ambulatory Health Services, OMB No.
0906–xxxx—NEW
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than August 8, 2019.
ADDRESSES: Submit your comments,
including the ICR Title, to the desk
officer for HRSA, either by email to
OIRA_submission@omb.eop.gov or by
fax to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Assessing Care and Health Outcomes
Among Ryan White HIV/AIDS Program
(RWHAP) Clients Who Do Not Receive
RWHAP-Funded Outpatient
Ambulatory Health Services (OAHS),
OMB No. 0906–xxxx—NEW.
Abstract: RWHAP is administered by
HRSA’s HIV/AIDS Bureau. RWHAP
funds and coordinates with cities,
states, and local clinics and communitybased organizations to deliver HIV care,
treatment, and support to low-income
people living with HIV (PLWH). Nearly
two-thirds of RWHAP clients live at or
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:47 Jul 08, 2019
Jkt 247001
below 100 percent of the federal poverty
level and about three-quarters are racial
or ethnic minorities. Since 1990,
RWHAP has developed a
comprehensive system of nearly 2,000
provider organizations that deliver high
quality health care and support services
to more than 500,000 PLWH, more than
50 percent of all diagnosed PLWH in the
United States. Recipients and
subrecipients funded to provide direct
services must submit client-level data
annually to HRSA as part of their
RWHAP Services Report (RSR). RSR
(0906–0039) contains a single record for
each RWHAP-eligible client who
received a service during the calendar
year. Providers report demographic and
service use data for all their clients.
However, they report clinical data
(including lab results) only for those
who received RWHAP-funded OAHS.
HRSA is embarking on a 24-month
study called Assessing Care and Health
Outcomes Among RWHAP Clients Who
Do Not Receive RWHAP-Funded OAHS.
The purpose of the study is to learn
about the quality of care and health
outcomes among the one-third of clients
for whom HRSA does not collect
clinical information—that is, for the
164,000 clients who do not receive
directly funded OAHS under the
RWHAP. HRSA will use the findings to
(1) assess HIV care and health outcomes
among its non-OAHS clients, (2)
determine if and where these clients
receive OAHS, (3) identify any unmet
HIV care and treatment needs faced by
this population, and (4) develop
strategies to better coordinate services
between RWHAP-funded and
nonfunded providers. To meet these
objectives, HRSA proposes to conduct
interviews and medical chart reviews at
30 sites. Sites include RWHAP-funded
providers that are not directly funded to
deliver OAHS and, if necessary for
accessing the medical records of their
non-OAHS clients, up to two nonRWHAP medical providers. At each site
visit, HRSA will collect qualitative and
quantitative information via (1)
semistructured interviews with program
managers, clinicians, and frontline
service providers, as well as with nonOAHS clients; and (2) medical chart
reviews for clients who do not receive
directly funded OAHS under the
RWHAP.
A 60-day Federal Register Notice was
published in the Federal Register on
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
April 8, 2019, vol. 84, No. 67; pp.
13934–35. There were no public
comments.
Need and Proposed Use of the
Information: The interviews with
provider staff and clients will provide
qualitative information on HIV-related
medical service use, process, and health
outcomes; barriers to care; unmet needs;
provider referral relationships; and
opportunities to improve care and
outcomes among clients who do not
receive directly funded OAHS under the
RWHAP. The medical chart reviews will
provide quantitative information on
medical visits, prescription
medications, and clinical outcomes for
a representative sample of non-OAHS
clients. HRSA will use the data to
estimate three main outcomes for the
study population: (1) Retention in care,
(2) initiation of antiretroviral therapy,
and (3) viral suppression. This
information will supplement data
available from the RSR on OAHS clients
and enable HRSA for the first time to
measure the quality of care and health
outcomes for its entire client
population, an important step toward
ending the HIV epidemic in the United
States.
Likely Respondents: HRSA plans to
conduct individual interviews with two
groups of informants: (1) Program
managers, case managers or other
frontline service providers, and medical
directors or clinicians; and (2) RWHAP
clients. HRSA also plans to review and
abstract key data elements from nonOAHS client medical records from
providers.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
E:\FR\FM\09JYN1.SGM
09JYN1
32753
Federal Register / Vol. 84, No. 131 / Tuesday, July 9, 2019 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Program Manager ................................................................
Case Manager .....................................................................
Medical Director ...................................................................
Client ....................................................................................
Medical Record Abstraction .................................................
Telephone Screening ...........................................................
30
30
40
120
30
45
1
1
1
1
50
1
30
30
40
120
1,500
45
1.00
1.00
1.00
.50
.08
.25
30.00
30.00
40.00
60.00
120.00
11.25
Total ..............................................................................
295
........................
1,765
........................
291.25
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–14535 Filed 7–8–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKBBV9HB2PROD with NOTICES
Number of
responses per
respondent
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Clinical and
Secondary Data Analysis Applications.
Date: August 2, 2019.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Eye Institute, 6700 B Rockledge
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeanette M. Hosseini,
Ph.D., Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 6700 B
Rockledge Drive, Suite 3400, Bethesda, MD
20892, 301–451–2020, jeanetteh@
mail.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI: Pathway to
Independence (K99) Applications.
Date: August 5–6, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:47 Jul 08, 2019
Jkt 247001
Place: National Institutes of Health,
National Eye Institute, 6700 B Rockledge
Drive, Suite 3400, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D.,
Scientific Review Administrator, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 6700 B
Rockledge Drive, Suite 3400, Bethesda, MD
20892.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: July 2, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–14487 Filed 7–8–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vascular and Hematology.
Date: July 30, 2019.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Endocrinology, Metabolism,
Nutrition and Reproductive Science.
Date: July 31, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Alexander D. Politis,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, (301) 435–
1150, politisa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Pediatric and Obstetric Pharmacology and
Therapeutics.
Date: July 31, 2019.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cognition and Perception.
Date: July 31, 2019.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
E:\FR\FM\09JYN1.SGM
09JYN1
]]>Agencies
[Federal Register Volume 84, Number 131 (Tuesday, July 9, 2019)]
[Notices]
[Pages 32752-32753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14535]
[[Page 32752]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; Assessing Care and Health
Outcomes Among Ryan White HIV/AIDS Program Clients Who Do Not Receive
RWHAP-Funded Outpatient Ambulatory Health Services, OMB No. 0906-xxxx--
NEW
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with of the Paperwork Reduction Act of 1995,
HRSA has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received no later than August 8,
2019.
ADDRESSES: Submit your comments, including the ICR Title, to the desk
officer for HRSA, either by email to [email protected] or by
fax to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Lisa Wright-Solomon, the
HRSA Information Collection Clearance Officer at [email protected] or
call (301) 443-1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Assessing Care and Health
Outcomes Among Ryan White HIV/AIDS Program (RWHAP) Clients Who Do Not
Receive RWHAP-Funded Outpatient Ambulatory Health Services (OAHS), OMB
No. 0906-xxxx--NEW.
Abstract: RWHAP is administered by HRSA's HIV/AIDS Bureau. RWHAP
funds and coordinates with cities, states, and local clinics and
community-based organizations to deliver HIV care, treatment, and
support to low-income people living with HIV (PLWH). Nearly two-thirds
of RWHAP clients live at or below 100 percent of the federal poverty
level and about three-quarters are racial or ethnic minorities. Since
1990, RWHAP has developed a comprehensive system of nearly 2,000
provider organizations that deliver high quality health care and
support services to more than 500,000 PLWH, more than 50 percent of all
diagnosed PLWH in the United States. Recipients and subrecipients
funded to provide direct services must submit client-level data
annually to HRSA as part of their RWHAP Services Report (RSR). RSR
(0906-0039) contains a single record for each RWHAP-eligible client who
received a service during the calendar year. Providers report
demographic and service use data for all their clients. However, they
report clinical data (including lab results) only for those who
received RWHAP-funded OAHS.
HRSA is embarking on a 24-month study called Assessing Care and
Health Outcomes Among RWHAP Clients Who Do Not Receive RWHAP-Funded
OAHS. The purpose of the study is to learn about the quality of care
and health outcomes among the one-third of clients for whom HRSA does
not collect clinical information--that is, for the 164,000 clients who
do not receive directly funded OAHS under the RWHAP. HRSA will use the
findings to (1) assess HIV care and health outcomes among its non-OAHS
clients, (2) determine if and where these clients receive OAHS, (3)
identify any unmet HIV care and treatment needs faced by this
population, and (4) develop strategies to better coordinate services
between RWHAP-funded and nonfunded providers. To meet these objectives,
HRSA proposes to conduct interviews and medical chart reviews at 30
sites. Sites include RWHAP-funded providers that are not directly
funded to deliver OAHS and, if necessary for accessing the medical
records of their non-OAHS clients, up to two non-RWHAP medical
providers. At each site visit, HRSA will collect qualitative and
quantitative information via (1) semistructured interviews with program
managers, clinicians, and frontline service providers, as well as with
non-OAHS clients; and (2) medical chart reviews for clients who do not
receive directly funded OAHS under the RWHAP.
A 60-day Federal Register Notice was published in the Federal
Register on April 8, 2019, vol. 84, No. 67; pp. 13934-35. There were no
public comments.
Need and Proposed Use of the Information: The interviews with
provider staff and clients will provide qualitative information on HIV-
related medical service use, process, and health outcomes; barriers to
care; unmet needs; provider referral relationships; and opportunities
to improve care and outcomes among clients who do not receive directly
funded OAHS under the RWHAP. The medical chart reviews will provide
quantitative information on medical visits, prescription medications,
and clinical outcomes for a representative sample of non-OAHS clients.
HRSA will use the data to estimate three main outcomes for the study
population: (1) Retention in care, (2) initiation of antiretroviral
therapy, and (3) viral suppression. This information will supplement
data available from the RSR on OAHS clients and enable HRSA for the
first time to measure the quality of care and health outcomes for its
entire client population, an important step toward ending the HIV
epidemic in the United States.
Likely Respondents: HRSA plans to conduct individual interviews
with two groups of informants: (1) Program managers, case managers or
other frontline service providers, and medical directors or clinicians;
and (2) RWHAP clients. HRSA also plans to review and abstract key data
elements from non-OAHS client medical records from providers.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
[[Page 32753]]
Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Program Manager................. 30 1 30 1.00 30.00
Case Manager.................... 30 1 30 1.00 30.00
Medical Director................ 40 1 40 1.00 40.00
Client.......................... 120 1 120 .50 60.00
Medical Record Abstraction...... 30 50 1,500 .08 120.00
Telephone Screening............. 45 1 45 .25 11.25
-------------------------------------------------------------------------------
Total....................... 295 .............. 1,765 .............. 291.25
----------------------------------------------------------------------------------------------------------------
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-14535 Filed 7-8-19; 8:45 am]
BILLING CODE 4165-15-P
